Mono Pharmacare IPO Grant Date: The Mono Pharmacare IPO share grant will close today (Friday, September 1). The investors who applied for the issuance can check the allotment status of the Mono Pharmacare IPO on the portal of the registrar, Bigshare Services Pvt Ltd.
Investors can use the allocation basis to find out whether and how many shares have been allocated to them. The refund process begins Tuesday, September 5 for those who were not granted shares. The allotment holders will receive their shares in their Demat accounts on Wednesday 6 September.
The listing date for Mono Pharmacare Limited has been set for Thursday 7th September on the NSE SME. If you applied for the shares, here’s how to check the Mono Pharmacare IPO grant status.
If you have applied for Mono Pharmacare’s IPO, you can check the status of your Mono Pharmacare IPO grant immediately on the website of IPO registrar Bigshare Services Pvt Ltd. check.
Also Read: Ratnaveer’s IPO is fully subscribed. GMP, subscription status, review, other details. Apply or not?
You can check the Mono Pharmacare IPO allocation status of your application at this link: https://ipo.bigshareonline.com/ipo_status.html
Step 1
Sign up using the direct Bigshare link – https://ipo.bigshareonline.com/ipo_status.html
step 2
In the Company Names section, select Mono Pharmacare IPO.
step 3
Select “Application number/CAF number or Beneficiary ID or PAN number”.
step 4
Click Search
Your Mono Pharmacare IPO allocation status will be displayed on your computer monitor on your mobile phone screen.
Mono Pharmacare IPO GMP today
Today’s Mono Pharmacare IPO GMP or gray market premium is +3, similar to the past five trading sessions. This suggests that Mono Pharmacare’s share price was trading at a premium of ₹3 in the gray market on Monday, according to topsharebrokers.com
Considering the high end of the IPO price range and the current gray market premium, the estimated listing price of Mono Pharmacare stock is ₹31 per piece, which is 10.71% higher than the IPO price of ₹28
According to topsharebrokers.com the lowest is GMP ₹0 while the highest is GMP ₹3.
“Grey market premium” indicates the willingness of investors to pay more than the issue price.
Also Read: Ratnaveer IPO: Issue Drawn 5.76 Times on First Day; NII, retail portion oversubscribed
Mono Pharmacare IPO details
The Mono Pharmacare IPO consists of a total of 53,00,000 new shares issued ₹14.84 crores. There is no OFS (Offer for Sale) component. According to the Company’s Red Herring prospectus, the Company intends to use gross proceeds to meet working capital needs; general business purposes; and to cover issuance costs.
Panilam Lakhatariya and Supal Lakhatariya are the promoters of the company.
The basis for the allotment of shares in Mono Pharmacare’s IPO will be determined on Monday, September 4th and the company will issue the refund on Tuesday, September 5th, while the shares will be issued on Wednesday, September 6th, September 5th The allotment recipients’ Demat account is expected to be credited on Thursday 7 September, listed on the NSE SME.
The lead manager of Mono Pharmacare Limited IPO is Unistone Capital Private Ltd and the registrar is Bigshare Services Private Ltd.
The core activities of Mono Pharmacare Limited are the marketing and distribution of pharmaceutical products. The Company offers cosmetics, analgesics and antipyretics, antacids and antiemetics, cough, cold and allergy products, antifungal, nutraceutical, cardiac and diabetic products and antibiotics.
The company is also a distributor for various pharmaceutical companies. As of February 28, 2023, the Company works with 168 pharmaceutical companies (distributors and stockists) and is also connected to 3,036 customers/vendors who, according to RHP, are a mix of pharmacy retailers and wholesalers.
Also Read: Mono Pharmacare IPO: GMP, Subscription Status On Day Three, Other Key Details
subjects
Comments are closed.